SP

Sunanda Prasad Sagar

Active Director Director DIN 11776496
DIN 11776496 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunanda Prasad Sagar

Sunanda Prasad Sagar is a Director at Vexora Pharmaceuticals Private Limited (since 2026).

DIN 11776496
Primary Designation Director
First Appointment 18 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jun 20262026Active

Board colleagues of Sunanda Prasad Sagar

NameDINCompanyDesignation
Prasad Ramakant Sagar11776495Vexora Pharmaceuticals Private LimitedDirector/Designated Partner
Siddhant Vijay Patil10687035Vexora Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Vexora Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sunanda Prasad Sagar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunanda Prasad Sagar

Sunanda Prasad Sagar currently holds 1 directorship: Vexora Pharmaceuticals Private Limited (Director, since 18 Jun 2026).

Sunanda Prasad Sagar was first appointed on 18 Jun 2026 as Director at Vexora Pharmaceuticals Private Limited.

The current boards of Sunanda Prasad Sagar's companies include Prasad Ramakant Sagar (Vexora Pharmaceuticals Private Limited), Siddhant Vijay Patil (Vexora Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available